Jul 2, 2025 10:00AM
Jun 25, 2025 02:24PM
Jun 13, 2025 04:25PM
Jun 13, 2025 04:22PM
Jun 5, 2025 06:01AM
Jun 2, 2025 07:07AM
Jun 2, 2025 07:05AM Regeneron Expands Clinical-Stage Obesity Portfolio with Strategic In-Licensing of Novel Dual GLP-1/GIP Receptor Agonist
May 19, 2025 07:43AM
May 19, 2025 07:07AM
May 19, 2025 07:06AM
May 19, 2025 07:04AM
Mar 15, 2025 04:00PM
Apr 10, 2024 04:59PM
Jan 30, 2024 07:03AM Regeneron (REGN) Announces Formation of Regeneron Cell Medicines with the Acquisition of 2seventy bio (TSVT) Platforms and Preclinical and Clinical Programs
Jan 30, 2024 07:00AM
Jan 8, 2024 12:12PM
Dec 27, 2023 05:05PM
Sep 25, 2023 08:35AM
Sep 25, 2023 08:34AM
Aug 9, 2023 07:32AM
Aug 9, 2023 07:30AM Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
May 4, 2023 06:30AM
Mar 24, 2023 08:49AM
Feb 3, 2023 06:30AM
Nov 3, 2022 06:30AM
Sep 16, 2022 07:16AM
Sep 16, 2022 07:15AM
Sep 16, 2022 07:15AM Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis
Aug 4, 2022 10:21AM
Aug 3, 2022 06:30AM
Jul 1, 2022 07:00AM
Jun 2, 2022 07:31AM
Jun 2, 2022 07:30AM
Jun 2, 2022 01:00AM
May 31, 2022 08:36AM Regeneron (REGN) Completes Checkmate Pharmaceuticals Acquisition
May 31, 2022 08:31AM
May 4, 2022 06:30AM
Apr 19, 2022 12:59PM
Apr 19, 2022 09:24AM
Apr 19, 2022 08:48AM
Apr 19, 2022 07:58AM
Apr 19, 2022 07:00AM Regeneron (REGN) Acquires Checkmate Pharmaceuticals (CMPI) for $10.50/sh Cash
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 19, 2022 07:00AM
Aug 6, 2021 09:22AM
Aug 5, 2021 06:19PM
May 6, 2021 06:30AM
Feb 11, 2021 02:01PM Regeneron (REGN) Announces FDA Approves First-in-class Evkeeza for Patients with Ultra-rare Inherited Form of High Cholesterol
Feb 11, 2021 02:00PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All